NLRP3 and hepatocellular carcinoma: NLRP3 inflammasome is regulated by the ERβ/mitogen-activated protein kinase (MAPK) pathway, and E2 regulates this pathway to inhibit the proliferation, migration, and colony formation ability of HCC cells (80).